These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17697547)

  • 1. [Clinical tolerance trial on recombinant human endostatin adenovirus].
    Cao Y; Li S; Li HL; Li YH; Zhang DS; Guo Y; Li XL; Lin XB; Huang WL; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):856-60. PubMed ID: 17697547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
    Li HL; Li S; Shao JY; Lin XB; Cao Y; Jiang WQ; Liu RY; Zhao P; Zhu XF; Zeng MS; Guan ZZ; Huang W
    Gene Ther; 2008 Feb; 15(4):247-56. PubMed ID: 18097470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
    Li JL; Liu HL; Zhang XR; Xu JP; Hu WK; Liang M; Chen SY; Hu F; Chu DT
    Gene Ther; 2009 Mar; 16(3):376-82. PubMed ID: 19092859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
    Kulke MH; Bergsland EK; Ryan DP; Enzinger PC; Lynch TJ; Zhu AX; Meyerhardt JA; Heymach JV; Fogler WE; Sidor C; Michelini A; Kinsella K; Venook AP; Fuchs CS
    J Clin Oncol; 2006 Aug; 24(22):3555-61. PubMed ID: 16877721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
    Khorana AA; Rosenblatt JD; Sahasrabudhe DM; Evans T; Ladrigan M; Marquis D; Rosell K; Whiteside T; Phillippe S; Acres B; Slos P; Squiban P; Ross M; Kendra K
    Cancer Gene Ther; 2003 Apr; 10(4):251-9. PubMed ID: 12679797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of malignant ascites with endostatin adenoviral vector].
    Wu Y; Zhao M; Yang L; Liu J; Wei YQ; Zhao X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):316-9. PubMed ID: 15181823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors.
    Lin X; Huang H; Li S; Li H; Li Y; Cao Y; Zhang D; Xia Y; Guo Y; Huang W; Jiang W
    Cancer Biol Ther; 2007 May; 6(5):648-53. PubMed ID: 17426445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of an E1B deleted adenovirus administered intratumorally to patients with cancer].
    Yuan ZY; Zhang L; Li S; Qian XZ; Guan ZZ
    Ai Zheng; 2003 Mar; 22(3):310-3. PubMed ID: 12654194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative].
    Wang FH; Li YH; Li S; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):501-4. PubMed ID: 16613689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity and stability analysis of endostatin purified from fermentation supernatant of 293 cells transfected with Ad/rhEndo.
    Liang Z; Wu J; Huang J; Tan W; Ke M; Liu R; Huang B; Xiao X; Zhao P; Huang W
    Protein Expr Purif; 2007 Dec; 56(2):205-11. PubMed ID: 17933553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
    Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up].
    Han DM; Huang ZG; Zhang W; Yu ZK; Wang Q; Ni X; Chen XH; Pan JH; Wang H
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2029-32. PubMed ID: 14703409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a recombinant adenoviral vector expressing human endostatin].
    Yuan AQ; He YL; Yang F; Liu MB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1769-71. PubMed ID: 17259117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
    Cunningham CC; Chada S; Merritt JA; Tong A; Senzer N; Zhang Y; Mhashilkar A; Parker K; Vukelja S; Richards D; Hood J; Coffee K; Nemunaitis J
    Mol Ther; 2005 Jan; 11(1):149-59. PubMed ID: 15585416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
    Su C; Na M; Chen J; Wang X; Liu Y; Wang W; Zhang Q; Li L; Long J; Liu X; Wu M; Fan X; Qian Q
    Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect by combination of recombinant endostatin adenovirus with carboplatin].
    Liao JQ; Su XQ; Peng XC; Shi HS; Zhang HL; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):386-9. PubMed ID: 20629304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.
    Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H
    J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostatin therapy reveals a U-shaped curve for antitumor activity.
    Tjin Tham Sjin RM; Naspinski J; Birsner AE; Li C; Chan R; Lo KM; Gillies S; Zurakowski D; Folkman J; Samulski J; Javaherian K
    Cancer Gene Ther; 2006 Jun; 13(6):619-27. PubMed ID: 16456550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].
    Chen CB; Pan JJ; Xu LY
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2033-5. PubMed ID: 14703410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.